ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,714.54
      -0.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sutro Biopharma Inc (STRO)

      7. Sutro Biopharma Inc (STRO) News

      STRO

      Sutro Biopharma (STRO)

      Sutro Biopharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:STRO
      DateTimeSourceHeadlineSymbolCompany
      05/17/20245:00PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:STROSutro Biopharma Inc
      05/13/20244:34PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STROSutro Biopharma Inc
      05/13/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
      05/13/20244:30PMGlobeNewswire Inc.Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated MilestonesNASDAQ:STROSutro Biopharma Inc
      04/30/20248:00AMGlobeNewswire Inc.Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 TrialNASDAQ:STROSutro Biopharma Inc
      04/02/20246:18AMGlobeNewswire Inc.Sutro Biopharma Announces Pricing of $75 Million Underwritten OfferingNASDAQ:STROSutro Biopharma Inc
      03/25/20244:30PMGlobeNewswire Inc.Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated MilestonesNASDAQ:STROSutro Biopharma Inc
      03/07/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      03/07/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      03/07/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      03/07/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      03/05/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      03/05/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      03/04/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      02/27/20244:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:STROSutro Biopharma Inc
      02/13/202412:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STROSutro Biopharma Inc
      02/12/20246:06AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STROSutro Biopharma Inc
      02/09/20244:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
      02/09/20244:25PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:STROSutro Biopharma Inc
      02/06/20244:05PMGlobeNewswire Inc.Sutro Biopharma to Participate in Upcoming Investor ConferencesNASDAQ:STROSutro Biopharma Inc
      01/31/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      01/29/20245:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STROSutro Biopharma Inc
      01/08/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
      01/04/20244:05PMGlobeNewswire Inc.Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADCNASDAQ:STROSutro Biopharma Inc
      12/14/20234:05PMGlobeNewswire Inc.Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024NASDAQ:STROSutro Biopharma Inc
      12/11/20234:05PMGlobeNewswire Inc.Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (luvelta) in Pediatric Patients with Relapsed/Refractory CBF/GLIS Presented at ASH 2023NASDAQ:STROSutro Biopharma Inc
      12/04/20234:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
      12/04/20234:05PMGlobeNewswire Inc.Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:STROSutro Biopharma Inc
      11/27/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
      11/27/20234:00PMGlobeNewswire Inc.Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine CandidatesNASDAQ:STROSutro Biopharma Inc
       Showing the most relevant articles for your search:NASDAQ:STRO